Aarkstore.com announces, The Latest market research report is available inits vast collection:Asthma – Pipeline Review, H2...
Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Asthma.- Identify...
List of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore....
Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.as...
Upcoming SlideShare
Loading in …5
×

Asthma – pipeline review, h2 2012

220 views
161 views

Published on

Aarkstore Enterprise-Asthma – pipeline review, h2 2012

Published in: Business
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
220
On SlideShare
0
From Embeds
0
Number of Embeds
6
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Asthma – pipeline review, h2 2012

  1. 1. Aarkstore.com announces, The Latest market research report is available inits vast collection:Asthma – Pipeline Review, H2 2012You can also request for sample page of above mention reports onsample@aarkstore.comSummaryGlobal Markets Direct’s, Asthma - Pipeline Review, Global Markets Direct’s, Asthma -Pipeline Review, H2 2012, provides an overview of the indication’s therapeuticpipeline. This report provides information on the therapeutic development forAsthma, complete with latest updates, and special features on late-stage anddiscontinued projects. It also reviews key players involved in the therapeuticdevelopment for Asthma. Asthma - Pipeline Review, Half Year is built using data andinformation sourced from Global Markets Direct’s proprietary databases,Company/University websites, SEC filings, investor presentations and featuredpress releases from company/university sites and industry-specific third partysources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Asthma.- A review of the Asthma products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.
  2. 2. Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Asthma.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.Table of contents:List of Tables 7List of Figures 11Introduction 12Global Markets Direct Report Coverage 12Asthma Overview 13Therapeutics Development 14An Overview of Pipeline Products for Asthma 14Asthma Therapeutics under Development by Companies 16Asthma Therapeutics under Investigation by Universities/Institutes 27Late Stage Products 30Comparative Analysis 30Mid Clinical Stage Products 31Comparative Analysis 31Early Clinical Stage Products 32Comparative Analysis 32Discovery and Pre-Clinical Stage Products 33Comparative Analysis 33Asthma Therapeutics – Products under Development by Companies 34Asthma Therapeutics – Products under Investigation by Universities/Institutes 48Companies Involved in Asthma Therapeutics Development 50Alcon, Inc. 50List of Figures
  3. 3. List of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H2 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H22012&PubId=&pagenum=1 Liver Cancer – Pipeline Review, H2 2012 Non-Small Cell Lung Cancer – Pipeline Review, H2 2012 Asthma – Pipeline Review, H2 2012 Multiple Sclerosis – Pipeline Review, H2 2012 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012 Diabetes – Pipeline Review, H2 2012 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,H2 2012 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012 Malaria – Pipeline Review, H2 2012 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,H2 2012 Dermatitis – Pipeline Review, H2 2012
  4. 4. Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: enquiry@aarkstore.com

×